This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity
and you are
over 20
years old
The phase for this study is not defined.
Show me locations

The purpose

To evaluate the effect of intravitreal bevacizumab with intravitreal triamcinolone for the treatment of central retinal vein occlusion (CRVO) presenting poor visual acuity.

Provided treatments

  • Procedure: intravitreal injection

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01053858. The sponsor of the trial is Hallym University Medical Center and it is looking for 38 volunteers for the current phase.
Official trial title: